These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3718653)

  • 1. The importance of obesity in the development of coronary risk factors and disease: the epidemiologic evidence.
    Hubert HB
    Annu Rev Public Health; 1986; 7():493-502. PubMed ID: 3718653
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obesity and cardiovascular morbidity].
    Berg A; Bönner G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood lipids profile in obese or overweight patients.
    Szczygielska A; Widomska S; Jaraszkiewicz M; Knera P; Muc K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):343-9. PubMed ID: 15323217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
    Gupta R; Gupta VP; Sarna M; Bhatnagar S; Thanvi J; Sharma V; Singh AK; Gupta JB; Kaul V
    Indian Heart J; 2002; 54(1):59-66. PubMed ID: 11999090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary risk factors in children of young coronary artery disease patients].
    Forti N; Diogo Giannini S; Diament J; Issa J; Fukushima J; Dal Bó C; Pereira Barretto AC
    Arq Bras Cardiol; 1996 Mar; 66(3):119-23. PubMed ID: 8762687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of hyperlipidemia, hypertension and obesity as coronary risk factors.
    Alexander JK
    Triangle; 1975; 14(1):1-8. PubMed ID: 1099746
    [No Abstract]   [Full Text] [Related]  

  • 7. [Framingham 36 years later].
    Castelli WP
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():11-5. PubMed ID: 3113392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
    Grover SA; Dorais M; Coupal L
    Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Göttingen Risk, Incidence and Prevalence (GRIPS) study. Recommendations for the prevention of coronary heart disease].
    Cremer P; Muche R
    Ther Umsch; 1990 Jun; 47(6):482-91. PubMed ID: 2375005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-cholesterol and HDL-cholesterol in ischaemic heart disease.
    Atukorala TM; Gunarathna PH; Ekanayake RA; Wijayawardhana UD
    Ceylon Med J; 1986 Mar; 31(1):9-14. PubMed ID: 3802308
    [No Abstract]   [Full Text] [Related]  

  • 11. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-lipid and lipoprotein patterns of Beijing populations from birth to senescence.
    Li JZ; Li PY; Niu QT; Wang S; Jiang L; Zhao SH; Guo HB; Gao H; Zhang ZM; Fang XZ
    Chin Med J (Engl); 1988 Sep; 101(9):659-64. PubMed ID: 3148409
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of a gerontologic longitudinal study--consequences].
    Hunecke I; Reuter W; Sauer I; Ries W
    Z Arztl Fortbild (Jena); 1989; 83(11):561-7. PubMed ID: 2773517
    [No Abstract]   [Full Text] [Related]  

  • 15. High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.
    Alessandri C; Basili S; Peverini F; Barsi R; Paradiso M; Coppotelli L; Violi F; Cordova C
    Clin Ter; 1992 Aug; 141(8):109-14. PubMed ID: 1395453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study.
    Canouï-Poitrine F; Luc G; Bard JM; Ferrieres J; Yarnell J; Arveiler D; Morange P; Kee F; Evans A; Amouyel P; Ducimetiere P; Empana JP;
    Cerebrovasc Dis; 2010 Aug; 30(3):252-9. PubMed ID: 20664258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of exercise in reducing coronary heart disease and associated risk factors.
    Leclerc KM
    J Okla State Med Assoc; 1992 Jun; 85(6):283-90. PubMed ID: 1474418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol and triglycerides. Numbers to count on.
    Mayo Clin Health Lett; 2001 Jul; 19(7):1-3. PubMed ID: 11433949
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.